• Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China;
XU Ting, Email: tingx2009@163.com
Export PDF Favorites Scan Get Citation

Objective  To systematically review the effectiveness and safety of erlotinib for the elderly with Non-small-cell lung cancer (NSCLC).
Methods  Databases including The Cochrane Library, PubMed, EMbase, CBM, VIP, CNKI and WanFang Data were electronically searched for relevant randomized controlled trails (RCTs). Two reviewers independently screened literature according to the inclusion and exclusion criteria, extracted data, and assessed the methodological quality. Then, meta-analysis was performed using RevMan 5.0 software.
Results  Totally 5 studies were included. The results of meta-analysis showed that, the objective response rate and stable disease rate was similar between the erlotinib group and the control group with no significant difference (RR=0.99, 95%CI 0.34 to 2.93, P=0.99; RR=1.17, 95%CI 0.95 to 1.43, P=0.14). The incidences of Grade Ⅲ-Ⅳ neutropenia and thrombocytopenia were lower in the erlotinib group than those in the control group (OR=0.12, 95%CI 0.03 to 0.52, P=0.005; OR=0.19, 95%CI 0.04 to 0.91, P=0.04); and the incidences of nausea and vomiting as wel as liver impairments were alike between the two groups (OR=0.93, 95%CI 0.12 to 7.08, P=0.95; OR=0.80, 95%CI 0.24 to 2.68, P=0.71); the incidences of diarrhea and skin rashes in the erlotinib group were higher (OR=5.96, 95%CI 1.28 to 27.88, P=0.02; OR=6.77, 95%CI 1.52 to 30.10, P=0.01).
Conclusion  Current evidence shows that, erlotinib is effective and safe in treating the elderly with NSCLC with better effects and no serious adverse reaction. However, due to the limited quantity and quality of the included studies, more high quality studies with large sample size and long-term follow-up are still needed to verify the above conclusion.

Citation: ZHAN Mei,LIU Xiao,LU Jing,XU Ting. Erlotinib for Elderly Patients with Non-Small-Cell Lung Cancer: A Systematic Review. Chinese Journal of Evidence-Based Medicine, 2013, 13(9): 1084-1089. doi: 10.7507/1672-2531.20130186 Copy

  • Previous Article

    Association between Thr241Met Polymorphism in XRCC3 Gene and the Risk of Lung Cancer in Chinese Population: A Meta-Analysis
  • Next Article

    Autologous Transplantation of Stem Cells for Diabetic Peripheral Neuropathy: A Systematic Review